| A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. |
18245462 |
Cancer Res |
| A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. |
18006806 |
Cancer Res |
| Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. |
29808028 |
Nat Genet |
| Antibody-based detection of ERG rearrangement-positive prostate cancer. |
20651988 |
Neoplasia |
| Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies. |
22849743 |
Arch Pathol Lab Med |
| Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy. |
26280815 |
Cancer |
| Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer. |
30291535 |
Med Oncol |
| Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. |
17409457 |
Cancer Res |
| Autoantibody signatures in prostate cancer. |
16177248 |
N Engl J Med |
| Beyond PSA: the next generation of prostate cancer biomarkers. |
22461644 |
Sci Transl Med |
| Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer. |
16678056 |
Urol Oncol |
| Characterization of KRAS rearrangements in metastatic prostate cancer. |
22140652 |
Cancer Discov |
| Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. |
23159737 |
Mol Cell |
| Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. |
18483239 |
Cancer Res |
| Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. |
18172298 |
Cancer Res |
| Classification and selection of biomarkers in genomic data using LASSO. |
16046820 |
J Biomed Biotechnol |
| Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. |
21600800 |
Urol Oncol |
| Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. |
17334343 |
Mod Pathol |
| Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer. |
23358695 |
Neoplasia |
| Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics. |
27159573 |
Prostate |
| Coordinated regulation of polycomb group complexes through microRNAs in cancer. |
21840484 |
Cancer Cell |
| Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden. |
23086769 |
Am J Clin Pathol |
| Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. |
21724842 |
Genome Res |
| Detection of somatic copy number alterations in cancer using targeted exome capture sequencing. |
22131877 |
Neoplasia |
| Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. |
38635241 |
|
| Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer. |
28344039 |
Cancer Cell |
| Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. |
17671502 |
Nature |
| Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer. |
31243372 |
Nature |
| Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. |
23233736 |
Cancer Res |
| Epigenomic alterations in localized and advanced prostate cancer. |
23555183 |
Neoplasia |
| Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. |
22610119 |
Nat Genet |
| Expressed pseudogenes in the transcriptional landscape of human cancers. |
22726445 |
Cell |
| From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer. |
22553170 |
J Pathol |
| Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. |
22101766 |
Nat Med |
| Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer. |
22952423 |
Neoplasia |
| Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. |
30033370 |
Cell |
| Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. |
15173267 |
J Natl Cancer Inst |
| Humoral response profiling reveals pathways to prostate cancer progression. |
18077443 |
Mol Cell Proteomics |
| Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer. |
27566105 |
Neoplasia |
| Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk. |
22496589 |
Proc Natl Acad Sci U S A |
| Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. |
23313952 |
Nat Genet |
| Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. |
29906450 |
Cell |
| Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer. |
27926866 |
Cell Rep |
| Integrating biomedical knowledge to model pathways of prostate cancer progression. |
17495538 |
Cell Cycle |
| Integrative analysis of genomic aberrations associated with prostate cancer progression. |
17804737 |
Cancer Res |
| Integrative clinical genomics of metastatic cancer. |
28783718 |
Nature |
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. |
16286247 |
Cancer Cell |
| Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. |
17996646 |
Cancer Cell |
| Integrative molecular concept modeling of prostate cancer progression. |
17173048 |
Nat Genet |
| Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. |
21575865 |
Cancer Cell |
| MiPanda: A Resource for Analyzing and Visualizing Next-Generation Sequencing Transcriptomics Data. |
30268942 |
Neoplasia |
| Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. |
17401460 |
Neoplasia |
| Molecular markers of prostate cancer. |
17138135 |
Urol Oncol |
| MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. |
36585434 |
Prostate Cancer Prostatic Dis |
| New strategies in prostate cancer: translating genomics into the clinic. |
23248095 |
Clin Cancer Res |
| Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target. |
22252602 |
Mol Cancer Ther |
| Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. |
17059688 |
Neoplasia |
| Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma. |
23348902 |
Mod Pathol |
| Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA. |
29245011 |
Cell |
| Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. |
17356713 |
Neoplasia |
| Pathway-directed weighted testing procedures for the integrative analysis of gene expression and metabolomic data. |
22497771 |
Genomics |
| Personalized oncology through integrative high-throughput sequencing: a pilot study. |
22133722 |
Sci Transl Med |
| Precision oncology in the age of integrative genomics. |
29319699 |
Nat Biotechnol |
| Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. |
20526349 |
Nat Med |
| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. |
16254181 |
Science |
| Role of the TMPRSS2-ERG gene fusion in prostate cancer. |
18283340 |
Neoplasia |
| Role of transcriptional corepressor CtBP1 in prostate cancer progression. |
23097625 |
Neoplasia |
| SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing. |
22787087 |
Cancer Discov |
| Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma. |
29941307 |
Eur Urol |
| SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. |
28292441 |
Cancer Cell |
| Systematic, evidence-based discovery of biomarkers at the NCI. |
22868876 |
Clin Exp Metastasis |
| TACO produces robust multisample transcriptome assemblies from RNA-seq. |
27869815 |
Nat Methods |
| The emergence of lncRNAs in cancer biology. |
22096659 |
Cancer Discov |
| The enzymatic activity of apoptosis-inducing factor supports energy metabolism benefiting the growth and invasiveness of advanced prostate cancer cells. |
23118229 |
J Biol Chem |
| The Landscape of Circular RNA in Cancer. |
30735636 |
Cell |
| The mutational landscape of lethal castration-resistant prostate cancer. |
22722839 |
Nature |
| The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. |
20622896 |
Oncogene |
| Therapeutic targeting of SPINK1-positive prostate cancer. |
21368222 |
Sci Transl Med |
| TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. |
21676887 |
Cancer Res |
| TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. |
16951139 |
Cancer Res |
| TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. |
17237811 |
Oncogene |
| TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. |
16585160 |
Cancer Res |
| Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. |
21804560 |
Nat Biotechnol |
| Transcriptomic heterogeneity in multifocal prostate cancer. |
30385730 |
JCI Insight |
| Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. |
21813756 |
Sci Transl Med |
| Whole transcriptome amplification for gene expression profiling and development of molecular archives. |
16611408 |
Neoplasia |
